Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

839496.pdf (1.03 MB)

Document type

Article

Version

Published version

Publication date

2024-01-10

Publication license

cc-by (c) Cabrerizo-Carreño, H. et al., 2024
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/207395

Impact of the implementation of a telemedicine program on patients diagnosed with asthma.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1186/s12890-024-02843-y

Abstract

Background: Asthma is one of the most common respiratory ailments worldwide. Despite broad understanding of the illness and of the available therapeutic options for it, patients with serious asthma suffer poor monitoring of their illness in 50% of cases. Aim: To assess the impact of the implementation of a mobile application (ESTOI) to control asthma in patients diagnosed with the illness, their adherence to treatment, and their perceived quality of life. Methodology: Randomized clinical trial with 52 weeks' follow-up of patients with asthma seen in a specialized hospital for their treatment in Spain. Some 108 included patients will be divided into two groups. The intervention group will undergo more exhaustive follow-up than normal, including access to the ESTOI application, which will have various categories of attention: control of symptoms, health recommendations, current treatment and personalized action plan, PEF record, nutritional plan, and chat access with a medical team. The asthma control questionnaire ACT is the main assessment variable. Other variables to be studied include an adherence test for the use of inhalers (TAI), the number of exacerbations, maximum exhalation flow, exhaled nitric oxide test, hospital anxiety and depression scale, asthma quality-of-life questionnaire, forced spirometry parameters (FVC, FEV1, and PBD), and analytic parameters (eosinophilia and IGE). The data will be collected during outpatient visits. Trial registration: This trial has registered at ClinicalTrials.gov (Identifier: NCT06116292).

Subject

Asma, Qualitat de vida, Salut en línia

Subject (English)

Asthma, Quality of life, Medical telematics

Citation

Collections

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Infermeria Fonamental i Clínica)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

CABRERIZO-CARREÑO, Héctor, et al. Impact of the implementation of a telemedicine program on patients diagnosed with asthma. BMC Pulmonary Medicine. 2024. Vol. 24. ISSN 1471-2466. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/207395

Export metadata

JSON - METS

Share record